Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
1765770
Reference Type
Journal Article
Title
Efficacy of 694-nm Q-Switched Ruby Fractional Laser Treatment of Melasma in Female Korean Patients
Author(s)
Jang, WooSun; Lee, CK; Kim, BJ; Kim, MNam
Year
2011
Is Peer Reviewed?
Yes
Journal
Dermatologic Surgery
ISSN:
1076-0512
EISSN:
1524-4725
Volume
37
Issue
8
Page Numbers
1133-1140
PMID
21585597
DOI
10.1111/j.1524-4725.2011.02018.x
Web of Science Id
WOS:000293287200009
Abstract
BACKGROUND Melasma is a common acquired symmetrical hypermelanosis of sun-exposed areas of the skin. Although the classical Q-switched ruby laser (QSRL) has been used successfully for the removal of tattoos and for the treatment of cutaneous pigmented lesions, its efficacy for melasma remains controversial. OBJECTIVE We used repeat low-dose fractional QSRL treatment for melasma and analyzed the clinical results. METHODS Fifteen Korean women with melasma were enrolled. Each patient received six low-dose fractional QSRL treatments to the face at 2-week intervals. Two investigators independently evaluated Melasma Area and Severity Index (MASI) scores before each session and 4 and 16 weeks after the final session. The intensities of pigmentation and erythema were assessed by measuring skin reflectance using a tristimulus color analyzer. RESULTS Mean MASI score decreased from 15.1 +/- 3.3 before treatment to 10.6 +/- 3.9 16 weeks after the final treatment. The lightness of pigmentation (L-value) increased from 56.6 +/- 3.5 before treatment to 59.9 +/- 2.8 16 weeks after the final treatment. CONCLUSIONS Multiple treatment sessions of low-dose fractional QSRL may be an effective strategy for the treatment of dermal or mixed-type melasma.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity